cell therapy β’ autoimmune β’ lupus
51 - 200 employees
Founded 2019
𧬠Biotechnology
π Pharmaceuticals
π¬ Science
π° $85M Series B on 2022-01
November 23
cell therapy β’ autoimmune β’ lupus
51 - 200 employees
Founded 2019
𧬠Biotechnology
π Pharmaceuticals
π¬ Science
π° $85M Series B on 2022-01
β’ Kyverna Therapeutics is a clinical-stage cell therapy company with the mission of engineering a new class of therapies for autoimmune diseases. β’ The Director of Medical Writing will be a key member of our Kyverna team responsible for leading and overseeing all medical writing activities across our portfolio of programs. β’ This role will require strategic thinking, strong leadership skills, and a deep understanding of medical writing best practices to ensure the preparation of high-quality documents.
β’ Advanced degree in life sciences, pharmacy, or related field (PhD, PharmD, MD, or equivalent). β’ Minimum of 5-8+ years of experience in medical writing, including experience in a leadership or management role. β’ Strong knowledge of global regulatory requirements and guidelines for document preparation (ICH, FDA, EMA). β’ Proven experience in preparing and editing a wide range of regulatory documents for clinical trials and submissions. β’ Track record of successful scientific publication writing and peer-reviewed journal submissions. β’ Excellent leadership, communication, and interpersonal skills. β’ Ability to effectively manage and mentor a team of medical writers and external contractors. β’ Detail-oriented with strong organizational and project management abilities.
Apply NowOctober 24
Manage construction underwriting solutions at CNA for National Accounts.
πΊπΈ United States β Remote
π° $883k Post-IPO Equity on 2016-09
β° Full Time
π΄ Lead
βοΈ Content Writer
October 17
Manage underwriting operations and lead a team of analysts for MSI's insurance solutions.
October 17
Oversee commercial property underwriting strategy at MSI to drive profitable growth.
October 17
Manage underwriting team at MSI, a leading MGA specializing in insurance solutions.
October 17
Oversee underwriting strategy for commercial property risk portfolio at MSI.